ghk cu stack with cjc 1295 ipamorelin safety interactions Emerging Peptide Therapies in Orthopaedics: Evidence, Safety, and Perioperative Implications ghk-cu interaction with cjc-1295 ipamorelin
Description
The only completed human trial (Sikiri et al., 2001, gastric cytoprotection) used oral BPC-157 over several weeks, not injectable musculoskeletal dosing
It includes a structured transition plan and a maintenance framework designed to hold what the window created
GHK-Cu cannot
If youre considering anything for personal use, thats a conversation for a qualified clinician not a Substack post
